Physician profile
Robert P Limoni
NPI 1548206444
$514,030.17
in general payments reported to CMS, 2019-2025
17 companies · $34K in 2025
The $34K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $368K · 2021: $5,159 · 2022: $64K · 2023: $22K · 2024: $20K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Travel and Lodging: $14K · Food and Beverage: $1,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $61,310.00 |
| Travel and Lodging | $14,308.35 |
| Food and Beverage | $1,141.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $412,961.79 | 2020-2022 | |
| Encore Medical, LP | $68,909.83 | 2019-2025 | Djo Surgical |
| Insight Medical Systems, INC. | $14,514.19 | 2021-2024 | Arvis |
| Si-Bone, INC. | $14,442.05 | 2020-2025 | |
| Stryker Corporation | $1,110.54 | 2021-2024 | Triathlon |
| Zimmer Biomet Holdings, INC. | $795.52 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $454.64 | 2024 | Iovera |
| Medacta USA, INC. | $292.03 | 2024 | |
| Uoc USA INC | $217.65 | 2024 | U2, Conformity, U-Motion II and Ustar II |
| Heron Therapeutics, INC. | $126.92 | 2025 | Zynrelef, Aponvie |
| Depuy Synthes Sales INC. | $65.84 | 2019 | |
| Organogenesis INC. | $44.82 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $39.57 | 2025 | |
| Cerapedics INC. | $23.92 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Deroyal Industries, INC. | $15.65 | 2025 | Prospera Flex Negative Pressure Wound Therapy System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $15.21 | 2024 | Ha Minuteman G3-R |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,118,822.17 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Limoni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.